Avik Pharmaceutical is an API and finished-dose manufacturer based in India. It holds 8 valid CEPs across a filed portfolio of 8 molecules. Its filings concentrate with MINSA (CR) and CDSCO (India). Its GMP standing is certified by CDSCO (India) and EMA. Customs aggregates show $3.9M of exports covering 237 molecules to 38 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Vapi, India | Not on file |
| g i d c vapi 396 195 valsad, India | Not on file |
| G.I.D.C., India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Prednisolone | EDQM, SFDA (Saudi Arabia) | 3 |
| Mometasone Furoate | EDQM | 2 |
| Beclomethasone Dipropionate | EDQM | 1 |
| Betamethasone Dipropionate | SFDA (Saudi Arabia) | 1 |
| Budesonide | EDQM | 1 |
| Clobetasol Propionate | EDQM | 1 |
| Clobetasone Butyrate | EDQM | 1 |
| Triamcinolone Acetonide | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 8 | None |
| CDSCO (India) | 1 | 2 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.0M | 22 |
| 2025 | Not reported | $3.9M | 38 |
| 2024 | Not reported | $2.9M | 35 |
| 2023 | Not reported | $1.7M | 23 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Avik Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free